From: <>! Subject: Report: Pharma Making Clinical Data More Systematically Available! Date: 7 Dec:12:27 GMT 1! To: <>! Reply-To: <reply-dd36a5713a-c0a10f7765-6df5@u - European industry federation - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-03-22 11:23:19 Clinical research European Federation of Pharmaceutical Industries and Associations Pharmaceutical industry Clinical trial Pharmaceutical Research and Manufacturers of America Data sharing Hoffmann-La Roche Pharmaceutical sciences Science Pharmacology		From: <>! Subject: Report: Pharma Making Clinical Data More Systematically Available! Date: 7 Dec:12:27 GMT+1! To: <>! Reply-To: Add to Reading List Source URL: openmedicineeu.blogactiv.eu Download Document from Source Website File Size: 151,96 KB Share Document on Facebook

	TAMIFLU - oseltamivir phosphate powder, for suspension TAMIFLU - oseltamivir phosphate capsule Hoffmann-La Roche Inc DESCRIPTION TAMIFLU (oseltamivir phosphate) is available DocID: 1v09s - View Document
	Panel II: SMA Drugs in Development • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Lawrence Charnas, MD, PhD, Sr. Translational Medicine Expert, Musculoskeletal Diseases, Novart DocID: 1sY97 - View Document
	Panel II: SMA Drugs in Development • Jinsy Andrews MD, Director of Clinical Research and Development, Cytokinetics • Thomas Blaettler MD, Global Clinical Development Team Leader, F. Hoffmann-La Roche • Jerry R. Men DocID: 1sY50 - View Document
	FERCAP Conference Empowering Stakeholders in Health Research: Towards Developing an Ethics of Accountability and Responsibility Beat Widler, F. Hoffmann-La Roche Bangkok , Thailand DocID: 1sI6G - View Document
	orlistat and pcoc orlistat 60 mg studies persistence analysis sibutramine orlistat, clinical studies orlistat, orlistat and gall stones does orlistat work, health problems and orlistat orlistat and appetite. orlistat pre DocID: 1rrCO - View Document